William Eduardo Sanchez MD

Clinical Trials

• Study to Evaluate Efficacy, Safety and Tolerability of HM15211(efocipegtrutide) in Subjects Start of enrollment: 2020 Jul 31

  RECRUITING

  PHASE2

• A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease Start of enrollment: 2021 Feb 24

  Terminated

  Phase 1

• Pilot Study to Evaluate the Long-term Chronic Care of Patients Who Could or do Utilize an Osseointegrated Device (OID) Start of enrollment: 2021 Jan 29

  Recruiting

• Assessment of e-Audiology for Providing Clinical Services and Support Start of enrollment: 2019 Aug 15

  Completed

  Not Applicable

• Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02 Start of enrollment: 2018 Feb 16

  Terminated

  Phase 3

• Hydrocortisone for BPD Start of enrollment: 2011 Aug 11

  COMPLETED

  PHASE3

• Strategies for Improving Proton Pump Inhibitors (PPIs) Prescription Associated to Non-steroidal Anti-inflammatory Drugs (NSAIDs) Start of enrollment: 2013 Jan 01

  Withdrawn

  Not Applicable

• AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) Start of enrollment: 2017 Apr 05

  Terminated

  Phase 3

• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) Start of enrollment: 2020 Jun 15

  ACTIVE_NOT_RECRUITING

  PHASE3

• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients Start of enrollment: 2018 Aug 30

  Recruiting

  Phase 3

• Statins for the Treatment of NASH Start of enrollment: 2023 Jan 25

  RECRUITING

  PHASE2

• Combined Active Treatment in Type 2 Diabetes with NASH Start of enrollment: 2021 Mar 26

  ACTIVE_NOT_RECRUITING

  PHASE4

• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis Start of enrollment: 2019 Mar 28

  Active, not recruiting

  Phase 3

• Multicenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubulization in Patients With Non-alcoholic Steatohepatitis (NASH-APOLLO). Start of enrollment: 2018 Apr 18

  Recruiting

  Not Applicable

• Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM Start of enrollment: 2012 Aug 01

  Completed

  Phase 2

• The Correlation Between the Pulmonary Function and Intrarenal Hemodynamics in 37 T2DM Patients in Early Period Start of enrollment: 2015 Sep 01

  Completed

• A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2021 Aug 14

  Completed

• Association of Carbamylated HDL and CAD in T2DM Patients Start of enrollment: 2018 Sep 01

  Completed

• Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations Start of enrollment: 2011 Nov 22

  Completed

• Brown Fat Tissue Related Hormone Levels in Metabolically Healthy and Unhealthy Obese Individuals Start of enrollment: 2021 Apr 01

  Completed

• Gut Microbiome and Obesity Start of enrollment: 2020 May 01

  Recruiting

• Chronic Kidney Disease and Non-alcoholic Fatty Liver Diseases Start of enrollment: 2021 Feb 28

  Completed

• Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology. Start of enrollment: 2020 Oct 28

  COMPLETED

  NA

• Join now to see all